Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).
about
A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. 1972N,N-diallyl-tyrosyl substitution confers antagonist properties on the kappa-selective opioid peptide [D-Pro10]dynorphin A(1-11)Preliminary analysis of 1H and 13C spectral and relaxation behavior in methionine-enkephalin6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides.Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds."Carba"-analogues of fentanyl are opioid receptor agonists.Morphine sulfate stimulates the adenylate cyclase in mouse caudate nuclei.Role of 2',6'-dimethyl-l-tyrosine (Dmt) in some opioid lead compoundsIdentification of two related pentapeptides from the brain with potent opiate agonist activity.N-methylated cyclic enkephalin analogues retain high opioid receptor binding affinity.New 2',6'-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligandsEvidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide, morphine-like compound in the central nervous system.Peptide neurons in the canine small intestine.Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivityComparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestineA neuroblastoma times glioma hybrid cell line with morphine receptorsEffects of narcotic analgesics and antagonists on the in vivo release of acetylcholine from the cerebral cortex of the cat.An analysis of the phenomenon of acute tolerance to morphine in the guinea-pig isolated ileum.A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferensEffect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesicsAssessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey.Opiate binding and effect in ileum preparations from normal and morphine pretreated guinea-pigs.Dopamine and the depressant action of morphine on stimulated guinea-pig ileum.The inhibitory effects of clonidine on the contractions of the guinea-pig ileum in the morphine-dependent and withdrawn states [proceedings]Pharmacological characterization of the presynaptic alpha-adrenoceptors regulating cholinergic activity in the guinea-pig ileum.Comparison of the receptor binding characteristics of opiate agonists interacting with mu- or kappa-receptors.The effects of morphine-like substances and their antagonists on transmission at the neuro-effector junction of the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum.Differential antagonism of the acutely lethal effects of organophosphates in rats.Evidence for the humoral control of the hypothalamic-pituitary-adrenal axis.Proceedings: Assessment of the agonist and antagonist activities of narcotic analgesic drugs by means of the mouse vas deferens.Development and in vitro characterization of a novel bifunctional μ-agonist/δ-antagonist opioid tetrapeptide.Bifunctional μ/δ opioid peptides: variation of the type and length of the linker connecting the two componentsEngineering endomorphin drugs: state of the art.[Met5]enkephalin acts via delta-opioid receptors to inhibit pelvic nerve-evoked contractions of cat distal colon.Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.Pre-incubation of guinea-pig myenteric plexus with beta-funaltrexamine: discrepancy between binding assays and bioassaysBremazocine is an agonist at kappa-opioid receptors and an antagonist at mu-opioid receptors in the guinea-pig myenteric plexus.Antagonism of GABAB-receptor-mediated responses in the guinea-pig isolated ileum and vas deferens by phosphono-analogues of GABA.
P2860
Q28237469-CE3401AA-6B6E-4E8C-8318-D1F59234B397Q28360093-87E9E9F3-CF9F-4397-8BE5-82609226D42DQ31502339-7A141B4F-2683-463B-AE37-A3D5102E2D43Q33246010-43DDDFB3-A469-4A36-A9DF-D451F88DA79DQ33613159-92CA70F7-9035-447D-9A18-ECD65FB380DCQ33735205-272C6126-572E-49A0-B970-BAA1FD1BA426Q33766279-FFAF154B-19F1-4070-B7E2-37BBC2165DCDQ33969604-EE18EE74-6B6D-4253-9D76-32DF137A6972Q34054021-582A6213-2AC0-43B0-915D-DFFEDE4B6523Q34134593-58E9B54C-E81D-4C4F-95AA-4D658DA64531Q34267124-3B9ACD62-58A6-4E3C-8EED-90AB023CB20BQ34317098-838B90F8-0185-4302-9BF9-C37DE07570CFQ34793128-B4097250-77D9-44C2-A7A2-8BB5D2EEE778Q35006597-3D02958C-A6AC-4F19-AFC0-CB2401B3B564Q35015450-F032645B-5E8F-4C1A-A080-300B8B5075DAQ35028911-D3E09E5C-A524-4B28-BFCC-FC0A703BDD42Q35041929-BBD5ADE6-FCFE-46B5-B53E-68E4B72D84BDQ35112282-0A2DA5C6-E991-47D2-8D2B-F787742C90F4Q35174297-F741CF6E-9CBE-47CC-B2B1-512C72011C72Q35174751-1AF95266-BC32-4838-8BC3-471287C33E60Q35174914-B6FC6B94-3CB3-481A-9F95-40C54914946EQ35175031-4A729508-5D77-4D19-A31B-F0BA335CF8D5Q35175512-068519C2-7587-4B9E-BAA8-943CC6D9BFB3Q35176639-5259714E-3729-4855-A3DE-8926E6F52955Q35176888-436706F0-EFEF-4356-8B58-7ED072DD511AQ35177545-802B35AF-EBF6-44FC-8A2D-DE0AF7D1CEEDQ35177759-63D269D7-5E53-4A83-B0F9-2C849A1B2516Q35177866-147A2226-BE20-4536-8B55-F4B3727A4F93Q35226108-8819E14A-4791-4FE3-AA0F-4A1C5627FE06Q35226145-2B12E824-88FC-4B0A-9808-DD529D3498F7Q35227010-F3E96A5A-A46F-4F23-B91A-A632B585FF61Q35601232-9CAF589F-CB4E-4D95-9E02-B84EF1455779Q35621534-03761A4D-ED7D-4F94-A1EE-6681F1227898Q35658766-1D51F814-A0AA-4DCC-B24A-684A1C393FCCQ35660653-B2FEE2BF-A86B-4796-A63F-A06BF6C23EBAQ35755001-E5DE221D-9C13-4821-B25B-C70FC175B7FEQ35872315-1825453C-02BB-4277-90D8-0DEA64F41760Q35886347-98063564-B456-43BB-A897-3FEB9C520618Q35887293-11CE6814-B636-4B55-ADD5-DF89A2A303C5Q35887844-75012D9B-3EE0-4E1B-83C3-93BCA0ECE67A
P2860
Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).
description
1968 nî lūn-bûn
@nan
1968 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1968 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1968年の論文
@ja
1968年論文
@yue
1968年論文
@zh-hant
1968年論文
@zh-hk
1968年論文
@zh-mo
1968年論文
@zh-tw
1968年论文
@wuu
name
Kinetic parameters of narcotic ...... llylnoroxymorphone (naloxone).
@ast
Kinetic parameters of narcotic ...... llylnoroxymorphone (naloxone).
@en
type
label
Kinetic parameters of narcotic ...... llylnoroxymorphone (naloxone).
@ast
Kinetic parameters of narcotic ...... llylnoroxymorphone (naloxone).
@en
prefLabel
Kinetic parameters of narcotic ...... llylnoroxymorphone (naloxone).
@ast
Kinetic parameters of narcotic ...... llylnoroxymorphone (naloxone).
@en
P2860
P1476
Kinetic parameters of narcotic ...... llylnoroxymorphone (naloxone).
@en
P2093
H W Kosterlitz
P2860
P304
P356
10.1111/J.1476-5381.1968.TB00988.X
P407
P577
1968-06-01T00:00:00Z